OSPHOS Trademark

Trademark Overview

On Thursday, August 31, 2006, a trademark application was filed for OSPHOS with the United States Patent and Trademark Office. The USPTO has given the OSPHOS trademark a serial number of 79031877. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, November 29, 2017. This trademark is owned by Jörg SCHWARZBICH. The OSPHOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, navicular inflammation drugs, [ osteoporosis drugs, ] osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ]; medicines for veterinary purposes, namely, navicular inflammation drugs, osteoporosis drugs, osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ]
osphos

General Information

Serial Number79031877
Word MarkOSPHOS
Filing DateThursday, August 31, 2006
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, November 29, 2017
Registration Number3356636
Registration DateTuesday, December 18, 2007
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 2, 2007

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations, namely, navicular inflammation drugs, [ osteoporosis drugs, ] osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ]; medicines for veterinary purposes, namely, navicular inflammation drugs, osteoporosis drugs, osteolysis drugs, [ substances which support osteosynthesis, ] calcium regulatory substances, calcium metabolism regulatory substances, bone metabolism regulatory substances [, drugs for the treatment of hypercalcemia caused by bone metastasis ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDechra Limited
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressNorthwich CW97UA
GB
Party NameOmnimedic GbR
Party Type30 - Original Registrant
Legal Entity Type02 - Partnership
AddressDE
Party NameOmnimedic GbR
Party Type20 - Owner at Publication
Legal Entity Type02 - Partnership
AddressDE
Party NameOmnimedic GbR
Party Type11 - New Owner Before Publication
Legal Entity Type02 - Partnership
AddressDE
Party NameJörg SCHWARZBICH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, June 28, 2007CHANGE OF OWNER RECEIVED FROM IB
Friday, July 13, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 14, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 15, 2006NEW APPLICATION ENTERED
Thursday, January 25, 2007ASSIGNED TO EXAMINER
Thursday, January 25, 2007NON-FINAL ACTION WRITTEN
Friday, January 26, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 26, 2007REFUSAL PROCESSED BY MPU
Friday, January 26, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 15, 2007REFUSAL PROCESSED BY IB
Thursday, October 25, 2007ASSIGNED TO EXAMINER
Friday, July 13, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 13, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 13, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 13, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 16, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, August 26, 2007ASSIGNED TO LIE
Sunday, August 26, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 12, 2007NOTICE OF PUBLICATION
Tuesday, October 2, 2007PUBLISHED FOR OPPOSITION
Thursday, June 12, 2014TEAS SECTION 71 RECEIVED
Tuesday, December 18, 2007REGISTERED-PRINCIPAL REGISTER
Monday, March 24, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 3, 2008CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, April 8, 2008FINAL DISPOSITION PROCESSED
Tuesday, April 8, 2008FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 28, 2008CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Thursday, May 29, 2008CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, July 10, 2008LIMITATION OF GOODS RECEIVED FROM IB
Friday, April 3, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 30, 2014NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, September 4, 2015NEW REPRESENTATIVE AT IB RECEIVED
Saturday, June 28, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 30, 2014REGISTERED-SEC.71 ACCEPTED
Thursday, July 3, 2014CHANGE OF OWNER RECEIVED FROM IB
Thursday, February 26, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 2, 2015PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, July 9, 2015INVALIDATION PROCESSED
Thursday, July 9, 2015PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, July 31, 2015PARTIAL INVALIDATION PROCESSED BY THE IB
Sunday, July 29, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, January 6, 2016NOTICE OF SUIT
Thursday, April 21, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 18, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, October 27, 2016INTERNATIONAL REGISTRATION RENEWED
Sunday, December 18, 2016COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, November 1, 2017TEAS SECTION 71 RECEIVED
Wednesday, November 29, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 29, 2017REGISTERED-SEC.71 ACCEPTED
Wednesday, November 29, 2017NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, August 3, 2018INVALIDATION PROCESSED
Saturday, July 29, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, September 23, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, September 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 14, 2018PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, August 3, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

osphos drugs substances regulatory metabolism calcium bone metastasis caused hypercalcemia treatment